Irwin Naturals Inc. completed the acquisition of Keta Media, LLC.
March 16, 2023
Share
Irwin Naturals Inc. (CNSX:IWIN) entered into an agreement to acquire Keta Media, LLC on September 29, 2022. The total consideration at closing will be paid in cash consideration, including the assumption of certain debts of Ketamine Media. The total consideration is to be paid in a combination of cash and stock, with the maximum payable contingent on a number of milestones related to profitability and operational goals. The transaction is subject to to certain customary closing condition and regulatory approvals.
Irwin Naturals Inc. (CNSX:IWIN) completed the acquisition of Keta Media, LLC on March 17, 2023. The total consideration paid in exchange for the membership interest consisted of $1,500 in cash paid at closing of the transaction and $1,500 payable within one year in cash. The pre-acquisition owner of KM is also eligible to receive additional consideration based on certain financial metrics.
Irwin Naturals Inc. (Irwin) is a nutraceutical company. The Company is engaged in distributing cannabidiol (CBD) products in mass-market and health food chain stores across the United States. Irwin's portfolio of herbal products is available in more than 100,000 retail doors across North America. The Company's full range of Vitamin, CBD, and Supplements features over 100 products, created to address mood and brain function, better sleep, sports performance, sexual health, immune support, weight management, women's health and men's health. The Company's ketamine clinic, Emergence, is an infusion clinic that offers intravenous (IV) ketamine for the treatment of depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety, bipolar disorder, migraines, and multiple chronic pain conditions such as complex regional pain syndrome (CRPS), reflex sympathetic dystrophy (RSD) and fibromyalgia.
IRWIN NATURALS INC. 